Swift’s 'Encore' Reissue Reignites 'Showgirl' Dominance Globally

Key points

• The album returned to No. 1 on the US Billboard 200 for its 13th nonconsecutive week, jumping from No. 21 after the 'Encore' release.
• In the US, the album earned 173,000 equivalent units in the tracking week, a 619% increase, with 78% of units driven by streaming of the four new tracks.
• 'Patient Zero' debuted at No. 1 in the UK and Australia, while 'Cleveland!' and 'Babylon' entered the top five in both countries.
• In the UK, the album and single achieved an 'Official Chart Double,' marking Swift’s second album to return to No. 1 on its one-year anniversary.
• The release was available only on streaming platforms and digital download, with no physical copies sold in the US for this cycle.

Background

The original album debuted at No. 1 in October 2025 and last held the top spot in January 2026. The 'Encore' edition, released on September 25, added four tracks written in Sweden with Max Martin and Shellback. Prior coverage noted mixed critical reception, with some arguing the release was a strategic move for award season, though the new tracks 'Babylon' and 'Pink Clouding' received praise for songwriting.

How outlets are covering it

Billboard and Hits Daily Double emphasize the massive US commercial surge, highlighting the 619% unit increase and streaming dominance. Official Charts focuses on the UK milestone, noting Swift’s first album to produce three No. 1 singles and her fifth 'Official Chart Double.' Effingham Radio highlights the global impact, specifically the Australian No. 1 debut. While Billboard and Hits Daily Double agree on the US numbers, Official Charts provides unique context on the UK singles chart performance, and Effingham Radio confirms the Australian chart movement, showing a consistent global trend of resurgence.

Why it matters

The 'Encore' reissue demonstrates the enduring commercial power of Taylor Swift’s catalog and her ability to reignite chart performance through strategic re-releases. The simultaneous No. 1 debuts in the US, UK, and Australia underscore her global dominance and the impact of new content on streaming metrics. This performance also sets the stage for potential award season recognition, as the album was nominated for Best Album at the 2026 MTV VMAs.

What to watch

The full Oct. 10, 2026-dated US Billboard 200 chart will be released on Oct. 6. In the UK, Swift’s 'Patient Zero' is expected to maintain its No. 1 position, and the album may continue to climb. In Australia, the album’s No. 1 debut may be followed by further chart movement for the new singles. The commercial success of the 'Encore' edition may influence future release strategies for Swift and other artists.